Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 21,130 shares at $50.11 ($1.0M) on 2025-03-20, disclosed to the SEC on 2025-03-20.
Open-market sale of $1.0M TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 3,643 | $169K | 16.7% |
| 2 | $46.29 | 3,643 | $169K | 16.7% |
| 3 | $47.40 | 3,557 | $169K | 16.7% |
| 4 | $47.40 | 3,557 | $169K | 16.7% |
| 5 | $50.11 | 3,365 | $169K | 16.7% |
| 6 | $50.11 | 3,365 |
| $169K |
| 16.7% |
| Total | $47.88 avg | 21,130 | $1.0M | 100% |
| Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |
| TARS | SELL | 2023-06-12 | $2K | — | Filing → |